#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary angioedema Extraskeletal ossification Osteosarcoma metastatic Osteochondrodysplasia Pyruvate kinase deficiency anaemia Glomerulonephritis chronic Retinoblastoma Proteus syndrome Ornithine transcarbamoylase deficiency Macular telangiectasia Deafness neurosensory Cystic fibrosis respiratory infection suppression Cardiomyopathy Necrotising enterocolitis neonatal PIK3CA related overgrowth spectrum More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Trials in Disease Familial amyotrophic lateral sclerosis – Basic Information Epidermolysis bullosa Turner’s syndrome – Life with Disease Hairy cell leukaemia recurrent – Basic Information Mucous membrane pemphigoid – Trials in Disease Mucopolysaccharidosis III – Life with Disease Congenital nephrogenic diabetes insipidus – Life with Disease Rhabdomyosarcoma recurrent – Life with Disease Cerebral arteriovenous malformation haemorrhagic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ivosidenib Chlorambucil Melatonin Belatacept Emtricitabine Midazolam Hydrochloride Birtamimab Amy109 Leflunomide At-1501 Soya Oil Damoctocog Alfa Pegol IPN01195 STREPTOCOCCUS PYOGENES Nomegestrol Acetate Tiapride Ads-010 Gd2Il18Cart Stx-241 SODIUM HYDROXIDE More therapies…

    Learn about Your Condition

    Metachromatic leukodystrophy Procedural pain Thrombocytopenia Hot flush Peritoneal dialysis Acarodermatitis Glomerulonephritis membranous Coronary artery bypass Frostbite Marfan's syndrome Piriformis syndrome Schizoaffective disorder Kawasaki's disease Pyelonephritis Primary hypercholesterolaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diagnosis

  • Study on the Safety and Effects of Regadenoson and Gadobutrol in Heart Imaging for Children with Cardiovascular Conditions

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Gadobutrol
    • Regadenoson
    France Greece Italy

  • Study on [68Ga]Ga-PentixaFor for Staging and Evaluation in Symptomatic Multiple Myeloma Patients in Initial Treatment or Relapse

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Pentixafor Gallium Ga-68
    France

  • Study Comparing Fluciclovine (18F) and Fluoroethyltyrosine F-18 PET Scans in Patients with New or Recurrent Brain Tumors and Brain Metastases

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    • Metastases to central nervous system
    Investigated Drugs:
    • Fluciclovine (18F)
    • Fluoroethyltyrosine F-18
    Germany

  • Study on Monitoring Metastatic Breast Cancer Response Using Fludeoxyglucose (18F) PET/CT for Patients with Metastatic Breast Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    Denmark

  • Study on Imaging Lung Aspergillosis Using Gallium-68 Deferoxamine for Patients with Pulmonary Aspergillosis

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Deferoxamine Mesilate
    • Gallium (68Ga) Chloride
    The Netherlands

  • Study on L-Carnitine and Cobamamide for Patients with Septic Shock and Acute Kidney Injury

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Cobamamide
    • Levocarnitine
    • Sodium Chloride
    France
Previous Page
1 … 18 19 20 21 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!